National
LGBTQ groups support Hurricane Fiona recovery efforts in Puerto Rico
Storm caused widespread flooding, island-wide blackout on Sept. 18
Eliana Rodríguez and her father Javier floated on a mattress and pieces of broken debris in flood water in Utuado, Puerto Rico, praying help would come for hours.
“The rain kept falling and never stopped,” Rodríguez said of the flood water that filled the home she shared with her father. “We sat in the dark when we lost power and when the water became too much, we prayed.”
Hurricane Fiona made landfall on Puerto Rico’s southwestern coast on Sept. 18, inundating Utuado and the surrounding area with 30 inches of rain.
Neighbors eventually rescued Rodríguez and her father. They have now relocated to New York with family, unsure when or if they will return.
Rodríguez still grieves for the things she lost in the flood that made her house a home.
“Mi isla es mi alma (my island is my soul),” Rodríguez said, choking back tears.
Fiona, which made landfall two days before the fifth anniversary of Hurricane Maria, knocked out power across Puerto Rico. People in the U.S. commonwealth since Fiona’s landfall continue to struggle with a lack of electricity, drinking water, food and medical necessities.
Rodríguez’s father, who has a heart condition, went without his medication until they reached the U.S. mainland, where they battled medical red tape to finally get the medication her father needs.
As recovery efforts continue to evolve on the island, humanitarian and grassroots organizations have flocked to “la Isla del Encanto” (the Island of Enchantment) to help Puerto Ricans rebuild.
Agriculture and infrastructure are among the hardest hit industries on the island.
“Hurricane Fiona destroyed $159 million bananas and other crops,” the island’s agricultural minister said.
Wilfred Labiosa, executive director of Waves Ahead Puerto Rico, an organization that offers support to marginalized and vulnerable communities, including the LGBTQ community, is helping with recovery efforts.
According to Labiosa, necessities like electricity, drinking water and mental health aid continue to be grave needs that are still unmet and the government is unsure when relief will come.
“They’re saying water is coming sooner than electricity, while getting electricity to some parts of the island could take months,” Labiosa told the Washington Blade during a telephone interview shortly after Fiona’s landfall.
Labiosa, along with many other Puerto Ricans, has sharply criticized the government for its lack of adequate leadership and oversight of LUMA Energy, the company that holds the exclusive contract to provide electricity to the island. LUMA Energy, which faces zero competition, has consistently failed to provide stable electricity to residents, even before the hurricane.
Waves Ahead, in collaboration with World Central Kitchen and José Andrés, provides meals for those in need across the island.
Like most small nonprofit organizations, Waves Ahead relies on donations and funds from the government to provide for those in need. And despite multiple visits by federal legislators, Waves Ahead has not been selected to receive federal aid funds, and Labiosa says that lawmakers do not mention the LGBTQ community in discussions of relief efforts.
Fiona’s effect are traumatic, Labiosa says the storm’s destruction hurts more because of the response from Puerto Rico’s central government and local municipalities.
“We haven’t learned anything in the last five years,” Labiosa said, referencing to Maria’s devastating effects.
Labiosa highlighted the burden of outdated infrastructure on the island, which the government has received millions of dollars to improve yet has not.
“The temporary bridge was supposed to be replaced two years ago,” Labiosa said in reference to Bridge PR-123 in Utuado that was built after Maria, and washed away the day Fiona made landfall.
Waves Ahead is also working on a partnership with the Ricky Martin Foundation to provide resources and help to all affected by Fiona, including focused efforts on the LGBTQ community.
Just like Labiosa, Arianna Lint, executive director of Arianna’s Center, is calling for mental health aid as well as other necessities.
“We have a very high suicide rate in our community,” Lint said.
For more than five years, Arianna’s Center has worked extensively in Puerto Rico, serving people of the LGBTQ community through community development and federal legislative efforts.
Recently, Lint delivered survival kits donated by Gilead Sciences around the island.
Lint and Gilead Sciences have partnered in an effort to ensure that those living with HIV/AIDS are receiving the medical care they need in the aftermath of the hurricane and destructive flooding.
“One of our largest aliados (allies) is Gilead Sciences, who is promoting the use of PrEP,” Lint said.
Parts of the island that remain inaccessible due to mudslides and debris from the storm are finding it hard to receive help, especially when it comes to health services for the elderly.
“Our greatest focus is on people left behind and senior people in our community,” Lint said.
As cleanup and recovery efforts continue in Puerto Rico, one thing is for sure: Cleanup will be a slow process, and many, like Rodriguez and her father, will be faced with the decision to leave their island or stay, uncertain when the cavalry will come.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Your guide to D.C.’s queer New Year’s Eve parties
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Using movement to boost your mental health during holidays
Reasons to be optimistic about 2026
America is going in the wrong direction for intersex children
Rush reopens after renewing suspended liquor license
Long-awaited ‘Pillion’ surpasses the sexy buzz
